Suneva Medical Celebrates Bellafill’s Steady Growth


Suneva Medical introduced Bellafill 10 years ago and has grown exponentially since the introduction of the product.

"We are focused on developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets,” said Preston Romm, Suneva Medical CEO. “The 10-year anniversary of Bellafill, along with its clinical evidence of safety and efficacy, is a very proud milestone for the company.”

Bellafill is a dermal filler for the correction of the nasolabial folds and reduces the appearance of “severe, atrophic, distensible facial acne scars on the cheeks” for patients over the age of 21.

The design of this product came after numerous market demands for a dermal filler that would have longer-lasting results and lesser chances of “treatment fatigue after routine treatments.” In a recent study, it was found that 71% of patients would be “extremely likely or very likely” to switch providers if a five-year filler was offered elsewhere.

With an emphasis on training, Suneva works hard to help medical professionals obtain the best patient outcomes. The company has pledged to offer comprehensive, professional training and online didactic training for Bellafill. 

More in MedSpa